Stocks were firm on Tuesday morning during a shortened week that will be full of economic reports. 24/7 Wall St. reviews dozens of analyst research reports each morning of the week for new ideas for our readers. Some of the analyst research reports cover stocks to buy, and some of them cover stocks to sell or to avoid.
As this is the first day of the second half of 2014, we already ran the best performing DJIA stocks and also the best performing S&P 500 stocks so far in 2014. These are this Tuesday’s top analyst upgrades, downgrades and initiations from Wall Street firms.
Amicus Therapeutics Inc. (NASDAQ: FOLD) already had a great Monday with a gain of more than 10% to $3.34, but the stock did rise as much as $4.06. Now we have two more upgrades: to Buy from Neutral at Janney with a $5 price target (from $2.50) and to Outperform from Market Perform at Leerink Swann.
comScore Inc. (NASDAQ: SCOR) was raised to Buy from Neutral and the price target was raised to $41 (versus a $35.48 close) by Goldman Sachs.
Expedia Inc. (NASDAQ: EXPE) was started with an Outperform rating and was assigned a $90 price target (versus a $78.76 close) at Oppenheimer.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.